DNA methylation and epigenetic defects in carcinogenesis

R Holliday1

  • 1Genetics Division, National Institute for Medical Research, London, Great Britain.

Mutation Research
|December 1, 1987
PubMed

Insights

DNA-damaging agents may cause cancer not just by mutation, but by altering DNA methylation, a key epigenetic control. This epigenetic alteration can lead to heritable changes in gene expression and potentially cancer.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Research

Background:

  • Carcinogenesis is often attributed to DNA mutations.
  • DNA methylation is a critical epigenetic mechanism regulating gene expression in mammalian cells.

Purpose of the Study:

  • To explore the role of DNA methylation changes as a mechanism for chemical carcinogenesis.
  • To investigate if carcinogens can alter epigenetic controls leading to heritable phenotypes.

Main Methods:

  • Review of existing evidence on DNA methylation and carcinogenicity.
  • Analysis of the link between epigenetic alterations and aberrant gene expression.

Main Results:

  • Evidence suggests DNA-damaging agents can induce heritable changes in DNA methylation.
  • Inhibition of DNA methylation has been linked to carcinogenicity.
  • Tumor cells exhibit altered DNA methylation patterns.

Conclusions:

  • Altered DNA methylation is a plausible mechanism by which carcinogens induce cancer.
  • Epigenetic dysregulation by carcinogens may lead to aberrant heritable phenotypes and cancer development.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...